Increasing Vaccine Uptake Among Adolescents in the Rural South
INVEST
A Tailored School-based Intervention to INcrease VaccinE Uptake Among adoleScenTs (INVEST) in the Rural South
1 other identifier
interventional
2
1 country
2
Brief Summary
The benefits of adolescent vaccines are well known for preventing meningococcal infection and human papillomavirus (HPV)-related pre-cancerous lesions. Yet, many adolescents in the United States (US) remain under-vaccinated, with vaccination rates among rural adolescents significantly lower than among their urban peers. In addition, there are urban-rural disparities in the coverage of HPV vaccine, particularly in Southern states like North and South Carolina, which currently fall below the Healthy People 2020 goal of ≥80% coverage. The goal of the proposed study is to evaluate the feasibility and preliminary efficacy of a school-based intervention for increasing vaccine uptake among adolescents in rural North and South Carolina.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2021
CompletedFirst Posted
Study publicly available on registry
August 10, 2021
CompletedStudy Start
First participant enrolled
August 31, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 3, 2022
CompletedResults Posted
Study results publicly available
December 4, 2024
CompletedDecember 10, 2025
November 1, 2025
1.2 years
August 5, 2021
October 11, 2023
November 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in the Percentage of Adolescents Who Ever Received at Least One Dose of HPV Vaccination in the Intervention Group After the Intervention Implementation Compared With Before Intervention Implementation
HPV vaccination status (received at least one versus no doses) of middle schoolers (by district) will be obtained from official vaccination records before and after intervention implementation.
Baseline, 9 months
Secondary Outcomes (2)
Difference in Percentage of Adolescents Who Have Completed the HPV Vaccination Series (2 Doses Depending on Age at Vaccination Initiation) in the Intervention Group After Implementation Compared With Before Intervention Implementation
Baseline, 9 months
Fidelity of Intervention Across Intervention Schools
9 months
Study Arms (1)
INVEST Intervention School Districts
EXPERIMENTALInterventions
The intervention will consist of 3 primary components: 1) school nurse training and technical support for promoting adolescent vaccination (Tdap, MenACWY, HPV) and strengthening existing school nursing vaccination programming, 2) caregiver-targeted educational materials that are disseminated via school nurses, and 3) tools and resources to facilitate linkage to vaccination providers in the local community. Existing materials will be used in the intervention such as resources available from the Centers for Disease Control and Prevention and Middle School Health Starts Here tool kit from the National Association of School Nurses and the National HPV Roundtable. Technical support includes the study team working with local school nurses to identify educational materials available from national and statewide sources.
Eligibility Criteria
You may qualify if:
- \- Any public middle school in Cherokee County, South Carolina or Rockingham County, North Carolina school districts
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- University of South Carolinacollaborator
Study Sites (2)
Duke University
Durham, North Carolina, 29340, United States
University of South Carolina
Columbia, South Carolina, 29208, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Chip Walter
- Organization
- Duke University - Duke Human Vaccine Institute
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuel Walter, MD, MPH
Duke University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2021
First Posted
August 10, 2021
Study Start
August 31, 2021
Primary Completion
November 3, 2022
Study Completion
November 3, 2022
Last Updated
December 10, 2025
Results First Posted
December 4, 2024
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share